Health

Results: 7837-7848 of 8083

PR Newswire associated0

Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

AviadoBio Announces Initiation of Phase 1/2 Clinical Trial, ASPIRE-FTD, Evaluating AVB-101 in People with Frontotemporal Dementia with GRN Mutations

PR Newswire associated0

Scorpion Therapeutics and Pierre Fabre Laboratories Announce First Patient Dosed in Phase 1/2 Clinical Trial of STX-721, a Mutant-Selective EGFR Exon 20 Inhibitor for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer

PR Newswire associated0

AlphaBiolabs: Leading testing laboratory launches the most powerful DNA relationship test available

Theramex Announces Agreement to Acquire the European Rights to Duphaston® and Femoston® From Viatris, Inc.

Elsevier launches new PharmaPendium, empowering pharma companies to bring novel drugs to market faster and increase success of regulatory submissions

Novotech Secures Consecutive Frost & Sullivan CRO Company of the Year Award

World Mental Health Day: Young people are more stressed about their finances than they are about social issues or climate change

Almirall R&D site at Sant Feliu de Llobregat (Barcelona, Spain) (Photo: Business Wire)

Centrient Pharmaceuticals joins Almirall’s growing innovation hub in Barcelona

XNK Therapeutics receives funding from Sweden's innovation agency Vinnova

PR Newswire associated0

Alimentiv and Satisfai Health Announce Commercial Availability of Highly Innovative AI-Powered Scoring Tool for the Assessment of Ulcerative Colitis in Stage I through IV Clinical Trials

Fujirebio and Sysmex Enter into Basic Agreement on Business Collaboration in the Field of Immunoassay